Value through Innovation27 July 2016

Clinical Study Results

  • Terbogrel - Healthy
    Clinical Study Number 528.204
    Study Indication Healthy
    Product Terbogrel
    Generic Name Terbogrel
    Lab Code
    Clinical Phase I
    Study Title

    Relative bioavailability and tolerability of two new different extended release capsules of 50 mg BIBV 308 SE each, versus a solution of 50 mg BIBV 308 SE administered orally twice a day for 3.5 days to healthy subjects (cross-over, open, randomised).

    Study Document Trial synopsis 528.204 english
  • Terbogrel - Healthy
    Clinical Study Number 528.22
    Study Indication Healthy
    Product Terbogrel
    Generic Name Terbogrel
    Lab Code
    Clinical Phase I
    Study Title

    Relative bioavailability and tolerability of various experimental formulations of 50 mg BIBV 308 SE administered orally twice a day over 3.5 days to healthy subjects (intraindividual comparison, open, partially randomised).

    Study Document Trial synopsis 528.22 english
  • Terbogrel - Healthy
    Clinical Study Number 528.23
    Study Indication Healthy
    Product Terbogrel
    Generic Name Terbogrel
    Lab Code
    Clinical Phase I
    Study Title

    Influence of oral doses of 75 mg Clopidogrel on the pharmacodynamics and safety of oral doses of 100 mg Terbogrel bid over 8 days in healthy male subjects. An intra-individual, open trial.

    Study Document Trial synopsis 528.23_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.